Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-25 @ 7:23 PM
NCT ID: NCT02174432
Description: None
Frequency Threshold: 0
Time Frame: Adverse events collected beginning with the first date and time of dosing through up to 50 weeks of dosing.
Study: NCT02174432
Study Brief: Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nalbuphine HCl ER nalbuphine HCl ER nalbuphine HCl ER: nalbuphine HCl ER BID for up to 50 weeks 0 None 2 36 0 36 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Bradycardia SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Joint injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications None View
Tenosynovitis stenosans SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Ulnocarpal abutment syndrome SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Other Events(If Any):